(PharmaNewsWire.Com, June 23, 2017 ) Neurologic disorders are defined as a change in the function of a nervous system. These are mainly caused due to structural change in activity of spinal cord, brain, and other nerves. These disorders are classified into three type’s namely Central nervous system disorders, Peripheral nervous system disorders, Autonomous nervous system disorders. Most of these disorders involve progressive decline in physical and mental capabilities that disrupts patient’s life. So the changes in the activity of brain can be witnessed due to brain injury, genetic disorders, changing lifestyle and other traumas. Hence, Nerotherapeutics are used for the treatment of various neurologic disorders.
The Latin America Neurotherapeutics Market is driven by increasing geriatric population, increasing health care expenditure, increasing investment in R&D, a better understanding of the nature of neurologic diseases. Restrictions by regulatory bodies on various technologies and drugs, Lack of awareness in developing countries, lack of proper reimbursement policy are the factors that are hindering the growth of the market.
Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others. Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders.
Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Based on Geography, the Latin America Neurotherapeutics market is analyzed under various regions namely Argentina, Brazil and Mexico. Some of the key Players influencing the Latin America Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.
Disorders •Introduction •Central Nervous system disorder •Peripheral Nervous system disorder •Autonomous Nervous system disorder
Distribution Channels •Introduction •Hospitals •Neurotherapeutic center •Clinical Research organisations •Clinics
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
